Transforming growth factor beta inhibits steroidogenic acute regulatory (StAR) protein expression in human ovarian

G R Attia1, C A Dooley, W E Rainey

  • 1Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

Insights

Transforming growth factor beta1 (TGFbeta1) inhibits steroid production and steroidogenic acute regulatory (StAR) protein expression in human ovarian cells. This suggests TGFbeta1 may impact follicular development by affecting StAR expression.

Area of Science:

  • Reproductive biology
  • Endocrinology
  • Cellular signaling

Background:

  • Steroidogenesis is crucial for ovarian function and follicular development.
  • The steroidogenic acute regulatory (StAR) protein is a key regulator of steroid hormone synthesis.
  • Transforming growth factor beta1 (TGFbeta1) is implicated in various reproductive processes.

Purpose of the Study:

  • To investigate the effects of TGFbeta1 on steroidogenesis in a human ovarian theca-like tumor (HOTT) cell model.
  • To determine the impact of TGFbeta1 on the expression of the steroidogenic acute regulatory (StAR) protein and its mRNA.
  • To elucidate the role of TGFbeta1 in regulating steroid production.

Main Methods:

  • Utilized a human ovarian theca-like tumor (HOTT) cell model.
  • Treated cells with TGFbeta1, forskolin, dibutyryl cyclic AMP (dbcAMP), and 22R-hydroxycholesterol.
  • Measured androstenedione production, combined steroid production, StAR protein expression, and StAR mRNA levels.

Main Results:

  • TGFbeta1 caused a dose-dependent inhibition of androstenedione production.
  • Combined steroid production was inhibited by TGFbeta1, particularly at higher concentrations and with 22R-hydroxycholesterol.
  • TGFbeta1 significantly suppressed both StAR protein and mRNA expression in a concentration-dependent manner.

Conclusions:

  • TGFbeta1 inhibits steroid production in ovarian theca cells.
  • TGFbeta1 exerts its inhibitory effects, at least partly, by downregulating StAR expression.
  • These findings suggest TGFbeta1 may influence ovarian follicular development through modulation of StAR.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral stimuli,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...